AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation of Medical and Social Care for Elderly Patients, Between Hospital and Home: TEMPORARY ACCOMMODATION Out of Hospitalization by Nursing Home and Long-Term Care Units in Ile-de-France Region

Recruitingn/aAges 60 Years - anyAllGérond'if
💬

In plain words

What the trial is, and whether it could suit you

Prospective, observational, non-interventional, comparative, multicenter RIPH3 study to investigate the impact of HTSH on length of hospital stay in referring services.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
* Inclusion Criteria: 1. Patient selection criteria * Patient male or female at least 60 years of age, as initially defined with the Regional Health Agency, discharged from hospital, * Oral expression of non opposition to participation in the study, documented in the medical record by the physician, * Presenting a defined and feasible plan for returning home, * Whose social/medical situation (stabilized) does not allow an immediate return home after hospitalization. 2. Caregiver selection criteria * Person with an unpaid caregiving activity for their relative in HTSH, * Person verbally expressing their non-opposition to participating in the study, and documented in the medical record of the patient they are helping, * A person who is able to understand the study questionnaires and evaluations, and is able to answer them without the help of a third party. 3. Professional selection criteria * Salaried professional, nursing or not, regularly and directly involved in the HTSH circuit, whether in hospital or in nursing home / long term care units, for at least 6 months, * Oral expression of non opposition to participation in the study, documented by the establishment. * Non-inclusion Criteria: * Be already included in another clinical study, * Benefit from a legal protection measure or be unable to express their consent, in accordance with article L1121-8 of the French Public Health Code.
💊

What it tests

  • Not listed
📍

Where

10 sites
Résidence ZEMGOR
Cormeilles-en-Parisis, France
EHPAD Pierre TABANOU
L'Haÿ-les-Roses, France
Groupe Hospitalier Sud Ile de France (GHSIF)
Melun, France
GHU Lariboisière
Paris, France
Broca Hospital
Paris, France
USDL Vaugirard, APHP
Paris, France
Centre Hospitalier de Rambouillet
Rambouillet, France
Centre Hospitalier de Versailles
Versailles, France

…and 2 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy